Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries
Wallner M, Biber ME, Stolfo D, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. Online 17 Apr 2024.
Leggi